191 related articles for article (PubMed ID: 36396015)
21. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
[No Abstract] [Full Text] [Related]
22. Radioactive Iodine Therapy of Graves' Disease in Patients Pretreated With Methimazole Without Radioiodine Uptake for Dose Estimation.
Mihailescu DV; Hoscheit C; Fogelfeld L
Endocr Pract; 2024 Apr; 30(4):333-339. PubMed ID: 38307459
[TBL] [Abstract][Full Text] [Related]
23. Treatment with propylthiouracil before radioactive iodine therapy is associated with a higher treatment failure rate than therapy with radioactive iodine alone in Graves' disease.
Tuttle RM; Patience T; Budd S
Thyroid; 1995 Aug; 5(4):243-7. PubMed ID: 7488862
[TBL] [Abstract][Full Text] [Related]
24. The occurrence of hypothyroidism following radioactive iodine treatment of toxic nodular goiter is related to the TSH level.
Adamali HI; Gibney J; O'Shea D; Casey M; McKenna TJ
Ir J Med Sci; 2007 Sep; 176(3):199-203. PubMed ID: 17632747
[TBL] [Abstract][Full Text] [Related]
25. Antithyroid drugs in Graves' hyperthyroidism: differences between "block and replace" and "titration" regimes in frequency of euthyroidism and Graves' orbitopathy during treatment.
Žarković M; Wiersinga W; Perros P; Bartalena L; Donati S; Okosieme O; Morris D; Fichter N; Lareida J; Daumerie C; Burlacu MC; Kahaly GJ; Pitz S; Beleslin B; Ćirić J; Ayvaz G; Konuk O; Törüner FB; Salvi M; Covelli D; Curro N; Hegedüs L; Brix T;
J Endocrinol Invest; 2021 Feb; 44(2):371-378. PubMed ID: 32524368
[TBL] [Abstract][Full Text] [Related]
26. Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy.
Watanabe S; Okamoto S; Akikawa K; Miyamoto N; Okamura-Kawasaki M; Uchiyama Y; Takenaka J; Toyonaga T; Hirata K; Kudo K
Ann Nucl Med; 2022 Nov; 36(11):923-930. PubMed ID: 35972673
[TBL] [Abstract][Full Text] [Related]
27. Discordant hypothyroxinemia and hypertriiodothyroninemia in treated patients with hyperthyroid Graves' disease.
Chen JJ; Ladenson PW
J Clin Endocrinol Metab; 1986 Jul; 63(1):102-6. PubMed ID: 2423547
[TBL] [Abstract][Full Text] [Related]
28. Comparison of long-term antithyroid drugs versus radioactive iodine or surgery for Graves' disease: A review of the literature.
El Kawkgi OM; Ross DS; Stan MN
Clin Endocrinol (Oxf); 2021 Jul; 95(1):3-12. PubMed ID: 33283314
[TBL] [Abstract][Full Text] [Related]
29. Incidence of Neonatal Hyperthyroidism Among Newborns of Graves' Disease Patients Treated with Radioiodine Therapy.
Yoshihara A; Iwaku K; Noh JY; Watanabe N; Kunii Y; Ohye H; Suzuki M; Matsumoto M; Suzuki N; Tadokoro R; Sekiyama C; Hiruma M; Sugino K; Ito K
Thyroid; 2019 Jan; 29(1):128-134. PubMed ID: 30426886
[TBL] [Abstract][Full Text] [Related]
30. [Comparison of the effectiveness of 131-I and antithyroid drugs in the treatment of Graves' disease in children].
Chen DY; Chen TH
Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):507-9. PubMed ID: 16083551
[TBL] [Abstract][Full Text] [Related]
31. Outcomes in Relapsed Graves' Disease Patients Following Radioiodine or Prolonged Low Dose of Methimazole Treatment.
Villagelin D; Romaldini JH; Santos RB; Milkos AB; Ward LS
Thyroid; 2015 Dec; 25(12):1282-90. PubMed ID: 26414885
[TBL] [Abstract][Full Text] [Related]
32. Evidence for higher success rates and successful treatment earlier in Graves' disease with higher radioactive iodine doses.
Sztal-Mazer S; Nakatani VY; Bortolini LG; Boguszewski CL; Graf H; de Carvalho GA
Thyroid; 2012 Oct; 22(10):991-5. PubMed ID: 22953990
[TBL] [Abstract][Full Text] [Related]
33. Radioactive Iodine: A Living History.
Daniels GH; Ross DS
Thyroid; 2023 Jun; 33(6):666-673. PubMed ID: 37307104
[No Abstract] [Full Text] [Related]
34. Prognostic factor analysis in 325 patients with Graves' disease treated with radioiodine therapy.
Yang D; Xue J; Ma W; Liu F; Fan Y; Rong J; Yang A; Yu Y
Nucl Med Commun; 2018 Jan; 39(1):16-21. PubMed ID: 29040161
[TBL] [Abstract][Full Text] [Related]
35. Predictors of euthyreosis in hyperthyroid patients treated with radioiodine
Stachura A; Gryn T; Kałuża B; Budlewski T; Franek E
BMC Endocr Disord; 2020 Jun; 20(1):77. PubMed ID: 32487052
[TBL] [Abstract][Full Text] [Related]
36. Influence of high tissue-absorbed dose on anti-thyroid antibodies in radioiodine therapy of Graves' disease patients.
Listewnik MH; Piwowarska-Bilska H; Jasiakiewicz K; Birkenfeld B
Adv Clin Exp Med; 2021 Sep; 30(9):913-921. PubMed ID: 34418335
[TBL] [Abstract][Full Text] [Related]
37. Prediction of therapeutic response to radioactive iodine in Graves' disease using TSH-receptor antibodies and HLA-status.
Davies TF; Platzer M; Farid NR
Clin Endocrinol (Oxf); 1982 Feb; 16(2):183-91. PubMed ID: 6121637
[TBL] [Abstract][Full Text] [Related]
38. [Clinical treatment with anti-thyroid drugs or iodine-131 therapy to control the hyperthyroidism of graves disease: a cost-effectiveness analysis].
Cruz Júnior AF; Takahashi MH; Albino CC
Arq Bras Endocrinol Metabol; 2006 Dec; 50(6):1096-101. PubMed ID: 17221117
[TBL] [Abstract][Full Text] [Related]
39. Postradioiodine Graves' management: The PRAGMA study.
Perros P; Basu A; Boelaert K; Dayan C; Vaidya B; Williams GR; Lazarus JH; Hickey J; Drake WM; Crown A; Orme SM; Johnson A; Ray DW; Leese GP; Jones TH; Abraham P; Grossman A; Rees A; Razvi S; Gibb FW; Moran C; Madathil A; Žarković MP; Plummer Z; Jarvis S; Falinska A; Velusamy A; Sanderson V; Pariani N; Atkin SL; Syed AA; Sathyapalan T; Nag S; Gilbert J; Gleeson H; Levy MJ; Johnston C; Sturrock N; Bennett S; Mishra B; Malik I; Karavitaki N
Clin Endocrinol (Oxf); 2022 Nov; 97(5):664-675. PubMed ID: 35274331
[TBL] [Abstract][Full Text] [Related]
40. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study.
Vannucchi G; Covelli D; Campi I; Currò N; Dazzi D; Rodari M; Pepe G; Chiti A; Guastella C; Lazzaroni E; Salvi M
Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
